Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles D Burger

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Pulmonary Circulation|February 12, 2024
Hemodynamic response to inhaled nitric oxide in patients with pulmonary hypertension and chronic kidney disease: A retrospective cohort studyKathryn T Del Valle, Michael J Krowka, Carrie A Schinstock, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|June 10, 2009
An alternative echocardiographic method to estimate mean pulmonary artery pressure: diagnostic and clinical implicationsJavier F Aduen, Ramon Castello, Marcelo M Lozano, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 4, 2020
Ambrisentan in portopulmonary hypertension: A multicenter, open-label trialIoana R Preston, Charles D Burger, Sonja Bartolome, et al.
Medrxiv : the Preprint Server for Health Sciences|May 11, 2021
LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIALZelalem Temesgen, Charles D Burger, Jason Baker, et al.
Mayo Clinic Proceedings|November 9, 2024
Echocardiography Screening of Consecutive Patients With Portal Hypertension Referred to Mayo Clinic for Liver Transplant EvaluationCharles D Burger, Hollie Saunders, David O Hodge, et al.
Annals of the American Thoracic Society|July 30, 2020
A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Process of CareJoshua D Lee, Charles D Burger, Genecelle B Delossantos, et al.
Mayo Clinic Proceedings|December 19, 2018
Interstitial Lung Disease and Other Pulmonary Manifestations in Connective Tissue DiseasesIsabel Mira-Avendano, Andy Abril, Charles D Burger, et al.
Transplantation Direct|February 12, 2025
The Utility of Follow-up Transthoracic Echocardiogram to Screen for Severe Portopulmonary Hypertension (POPH) in Patients Granted POPH Model for End-stage Liver Disease (MELD) ExceptionsKathryn T Del Valle, Dana Kay, Michael J Krowka, et al.
Transplantation Direct|November 18, 2020
Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients With a Mean Pulmonary Arterial Pressure ≥35 mm HgHilary M DuBrock, James R Runo, Corey J Sadd, et al.
Chest|February 18, 2019
Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment StrategiesRaymond L Benza, Mardi Gomberg-Maitland, C Greg Elliott, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Pulmonary Circulation|February 12, 2024
Hemodynamic response to inhaled nitric oxide in patients with pulmonary hypertension and chronic kidney disease: A retrospective cohort studyKathryn T Del Valle, Michael J Krowka, Carrie A Schinstock, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|June 10, 2009
An alternative echocardiographic method to estimate mean pulmonary artery pressure: diagnostic and clinical implicationsJavier F Aduen, Ramon Castello, Marcelo M Lozano, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 4, 2020
Ambrisentan in portopulmonary hypertension: A multicenter, open-label trialIoana R Preston, Charles D Burger, Sonja Bartolome, et al.
Medrxiv : the Preprint Server for Health Sciences|May 11, 2021
LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIALZelalem Temesgen, Charles D Burger, Jason Baker, et al.
Mayo Clinic Proceedings|November 9, 2024
Echocardiography Screening of Consecutive Patients With Portal Hypertension Referred to Mayo Clinic for Liver Transplant EvaluationCharles D Burger, Hollie Saunders, David O Hodge, et al.
Annals of the American Thoracic Society|July 30, 2020
A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Process of CareJoshua D Lee, Charles D Burger, Genecelle B Delossantos, et al.
Mayo Clinic Proceedings|December 19, 2018
Interstitial Lung Disease and Other Pulmonary Manifestations in Connective Tissue DiseasesIsabel Mira-Avendano, Andy Abril, Charles D Burger, et al.
Transplantation Direct|February 12, 2025
The Utility of Follow-up Transthoracic Echocardiogram to Screen for Severe Portopulmonary Hypertension (POPH) in Patients Granted POPH Model for End-stage Liver Disease (MELD) ExceptionsKathryn T Del Valle, Dana Kay, Michael J Krowka, et al.
Transplantation Direct|November 18, 2020
Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients With a Mean Pulmonary Arterial Pressure ≥35 mm HgHilary M DuBrock, James R Runo, Corey J Sadd, et al.
Chest|February 18, 2019
Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment StrategiesRaymond L Benza, Mardi Gomberg-Maitland, C Greg Elliott, et al.
Pageof 9